Advertising
BUY
It looks good it will get FDA approval for a Covid vaccine for children. Any good news here will help PFE. He's owned this for a while. The current pullback is a buying opportunity.
biotechnology / pharmaceutical
PARTIAL SELL
The easy money has been made, but he doesn't see a pullback. He doesn't see much upside. Take profits. The lumber outlook for 2022 is decent, but valuations are rich in these stocks.
west coast forestry
BUY
Likes this pharma. It offers decent dividend growth and the dividend is safe. He holds pharma long term and didn't sell during Covid. Post-Covid, focus will return to non-Covid drugs, like BMY's cancer treatment.
biotechnology / pharmaceutical
BUY
It's not overvalued but margins could be challenged going forward. Will deliver decent results in the short/medium-term. Some think the valuation is stretched. Their war chest is huge and could fuel more buying in coming years.
food stores
PARTIAL SELL
It's a tough one. It's a bet on the near-term future on corporate jets. It's a huge debate given Covid. Jets are safer than commercial flights. Then again, businesspeople can meet on Zoom, not in person after a flight. Also, companies are getting scored on ESG and private jets score negatively. Take profits.
transportation equip & components
DON'T BUY
See his comments about Bombardier. He'll watch the airline space but isn't buying any at the moment.
Transportation
TOP PICK
A key reason to buy this is their move into supplying technology for EVs. They have the expertise and EVs will only grow. Buy for 5-10 years. (Analysts’ price target is $10.61)
electrical / electronic